UNSPSC 85695515: Supplement right carpal with synthetic substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right carpal with synthetic substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0PUM3JZ

UNSPSC 85695515 Supplement right carpal with synthetic substitute, percutaneous approach is a Commodity code that shows no relevant recent state and local procurement activity. The five most recent opportunities posted under this code—covering inmate medical and pharmacy services in Georgia, pharmacy benefit management in Florida, virtual primary and urgent care in Florida, peer support services in California, and fire department medical director services in California—bear no substantive relationship to orthopedic carpal supplementation or percutaneous surgical procedures. The code appears to have been misapplied across these solicitations, which span correctional health administration, pharmacy claims management, virtual care platforms, behavioral health peer support, and emergency medical services oversight—none of which involve the orthopedic implant or surgical procedure the code nominally describes.

State and local procurement bodies do not currently solicit carpal supplementation services or related orthopedic implants under this code. The mismatch between the code's clinical scope and the actual work being bought suggests either systematic tagging error in the underlying database or a code-to-opportunity linkage that does not reflect real purchasing demand. Firms evaluating this code for business development purposes should verify the correct UNSPSC classification if they provide orthopedic implants or surgical services to state and local health systems, correctional facilities, or employee health plans; the current code does not surface genuine procurement signals in those markets.